10X Genomics Inc vs Williams Companies Inc — how do they compare? 10X Genomics Inc trades at $58.7 (market cap $7.61B), while Williams Companies Inc trades at $71.97 (market cap $88.45B). The key difference: Williams Companies Inc is far larger — about 11.6× 10X Genomics Inc's market cap, and Williams Companies Inc pays a 2.9% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | WMB | |
|---|---|---|
Market Cap | $7.61B | $88.45B |
Sector | Health | Energy |
52-Week High | $58.57 | $79.40 |
52-Week Low | $11.34 | $56.51 |
Enterprise Value | $7.14B | $119.07B |
Dividend Yield | — | 2.9% |
Trailing returns across standard periods
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →